- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe active rheumatoid arthritis
- Meeting Date: November 2009
- Public Summary Document (PSD) November 2009 PBAC Meeting - PDF
Tocilizumab – November 2009
Tocilizumab, solution for I.V. infusion, 80 mg in 4 mL, 200 mg in 10 mL and 400 mg in 20 mL, Actemra® , November 2009
Last updated
5 March 2010